Publication: Galactosaminogalactan activates the inflammasome to provide host protection
| dc.contributor.author | Briard, Benoit | |
| dc.contributor.author | Fontaine, Thierry | |
| dc.contributor.author | Samir, Parimal | |
| dc.contributor.author | Place, David E | |
| dc.contributor.author | Muszkieta, Laetitia | |
| dc.contributor.author | Malireddi, R K Subbarao | |
| dc.contributor.author | Karki, Rajendra | |
| dc.contributor.author | Christgen, Shelbi | |
| dc.contributor.author | Bomme, Perrine | |
| dc.contributor.author | Vogel, Peter | |
| dc.contributor.author | Beau, Rémi | |
| dc.contributor.author | Mellado, Emilia | |
| dc.contributor.author | Ibrahim-Granet, Oumaima | |
| dc.contributor.author | Henrissat, Bernard | |
| dc.contributor.author | Kalathur, Ravi C | |
| dc.contributor.author | Robinson, Cam | |
| dc.contributor.author | Latgé, Jean-Paul | |
| dc.contributor.author | Kanneganti, Thirumala-Devi | |
| dc.contributor.funder | NIH - National Cancer Institute (NCI) (Estados Unidos) | |
| dc.contributor.funder | National Institutes of Health (Estados Unidos) | |
| dc.contributor.funder | Fondation pour la recherche médicale (Francia) | |
| dc.date.accessioned | 2025-01-09T11:16:11Z | |
| dc.date.available | 2025-01-09T11:16:11Z | |
| dc.date.issued | 2020-12 | |
| dc.description | Publisher Correction: Galactosaminogalactan activates the inflammasome to provide host protection. Nature. 2021 Jan;589(7841):E3. doi: 10.1038/s41586-020-03088-5. PMID: 33349706 | |
| dc.description.abstract | Inflammasomes are important sentinels of innate immune defence that are activated in response to diverse stimuli, including pathogen-associated molecular patterns (PAMPs). Activation of the inflammasome provides host defence against aspergillosis, which is a major health concern for patients who are immunocompromised. However, the Aspergillus fumigatus PAMPs that are responsible for inflammasome activation are not known. Here we show that the polysaccharide galactosaminogalactan (GAG) of A. fumigatus is a PAMP that activates the NLRP3 inflammasome. The binding of GAG to ribosomal proteins inhibited cellular translation machinery, and thus activated the NLRP3 inflammasome. The galactosamine moiety bound to ribosomal proteins and blocked cellular translation, which triggered activation of the NLRP3 inflammasome. In mice, a GAG-deficient Aspergillus mutant (Δgt4c) did not elicit protective activation of the inflammasome, and this strain exhibited enhanced virulence. Moreover, administration of GAG protected mice from colitis induced by dextran sulfate sodium in an inflammasome-dependent manner. Thus, ribosomes connect the sensing of this fungal PAMP to the activation of an innate immune response. | |
| dc.description.peerreviewed | Sí | |
| dc.description.sponsorship | We thank members of the Kanneganti laboratory for their comments, suggestions and technical assistance; R. Tweedell for scientific editing of the manuscript; the St Jude Children’s Research Hospital Veterinary Pathology Core, SJCRH Center for Proteomics and Metabolomics and SJCRH Cell and Tissue Imaging Center (supported by the NCI P30 CA021765); D. Sheppard for sharing the A. fumigatus deletion mutant ∆agd; and V. M. Dixit and N. Kayagaki for the Casp1−/−Casp11−/− mutant mouse strain. T.-D.K. is supported by NIH grants AI101935, AI124346, AR056296 and CA253095 and by the American Lebanese Syrian Associated Charities. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. J.-P.L. is supported by the Aviesan project Aspergillus, the French Government’s Investissement d’Avenir program, Laboratoire d’Excellence ‘Integrative Biology of Emerging Infectious Diseases’ (grant number ANR-10-LABX-62-IBEID) and la Fondation pour la Recherche Médicale (DEQ20150331722 LATGE Equipe FRM 2015). | |
| dc.format.number | 7839 | |
| dc.format.page | 688-692 | |
| dc.format.volume | 588 | |
| dc.identifier.citation | Briard B, Fontaine T, Samir P, Place DE, Muszkieta L, Malireddi RKS, Karki R, Christgen S, Bomme P, Vogel P, Beau R, Mellado E, Ibrahim-Granet O, Henrissat B, Kalathur RC, Robinson C, Latgé JP, Kanneganti TD. Galactosaminogalactan activates the inflammasome to provide host protection. Nature. 2020 Dec;588(7839):688-692. | |
| dc.identifier.doi | 10.1038/s41586-020-2996-z | |
| dc.identifier.e-issn | 1476-4687 | |
| dc.identifier.issn | 0028-0836 | |
| dc.identifier.journal | Nature | |
| dc.identifier.other | https://pmc.ncbi.nlm.nih.gov/articles/PMC8086055/ | |
| dc.identifier.pubmedID | 33268895 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12105/25973 | |
| dc.language.iso | eng | |
| dc.publisher | Nature Publishing Group | |
| dc.relation.publisherversion | https://doi.org/10.1038/s41586-020-2996-z | |
| dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología (CNM) | |
| dc.repisalud.institucion | ISCIII | |
| dc.rights.accessRights | open access | |
| dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject.mesh | Animals | |
| dc.subject.mesh | Aspergillosis | |
| dc.subject.mesh | Aspergillus fumigatus | |
| dc.subject.mesh | Biofilms | |
| dc.subject.mesh | Colitis | |
| dc.subject.mesh | Dextran Sulfate | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Fungal Proteins | |
| dc.subject.mesh | Gene Deletion | |
| dc.subject.mesh | Immunity, Innate | |
| dc.subject.mesh | Inflammasomes | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Mice | |
| dc.subject.mesh | NLR Family, Pyrin Domain-Containing 3 Protein | |
| dc.subject.mesh | Pathogen-Associated Molecular Pattern Molecules | |
| dc.subject.mesh | Polysaccharides | |
| dc.subject.mesh | Protein Biosynthesis | |
| dc.subject.mesh | Ribosomal Proteins | |
| dc.subject.mesh | Ribosomes | |
| dc.title | Galactosaminogalactan activates the inflammasome to provide host protection | |
| dc.type | research article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | f189cece-f159-4ab4-b47d-ec72ca9af3e2 | |
| relation.isAuthorOfPublication.latestForDiscovery | f189cece-f159-4ab4-b47d-ec72ca9af3e2 | |
| relation.isFunderOfPublication | b589134c-ce3e-4f64-a3f5-83d0a7eb706a | |
| relation.isFunderOfPublication | d863b318-3e6b-4cfc-81bb-a6d112b1f86e | |
| relation.isFunderOfPublication | 6de8a756-6a00-4fbd-9a7b-28ae46d553b2 | |
| relation.isFunderOfPublication.latestForDiscovery | b589134c-ce3e-4f64-a3f5-83d0a7eb706a | |
| relation.isPublisherOfPublication | 301fb00e-338e-4f8c-beaa-f9d8f4fefcc0 | |
| relation.isPublisherOfPublication.latestForDiscovery | 301fb00e-338e-4f8c-beaa-f9d8f4fefcc0 |


